Versartis Inc.

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Terminated	A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency Growth Hormone Deficiency	Phase 3	2017-03-31
Terminated	Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)	Phase 2	2016-02-11
Completed	Long-Acting Growth Hormone in Children Compared to Daily rhGH Growth Disorders	Phase 3	2015-08-26
Terminated	Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting G Pediatric Growth Hormone Deficiency, Growth Disorders	Phase 2 / Phase 3	2015-08-08
Completed	Versartis International Trial in Adults With Long-Acting Growth Hormone Adult Growth Hormone Deficiency	Phase 2	2015-07-01
Terminated	Versartis Long-Term Safety Study of Somavaratan Pediatric Growth Hormone Deficiency	Phase 2 / Phase 3	2014-03-03
Completed	Versartis Trial in Children to Assess Long-Acting Growth Hormone Pediatric Growth Hormone Deficiency	Phase 1 / Phase 2	2012-10-01
Completed	VRS-317 in Adult Subjects With Growth Hormone Deficiency Growth Hormone Deficiency	Phase 1	2011-03-01